About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
R
SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease
By
Rita Jermyn
8,170 views
April 12, 2022
1 Comment
Login to view comments.
Click here to Login
Featured Video
18:06
Lilly Obesity
Getting Patients Started with an Obesity Treatment Option for Adults
Feat.
E. Lazarus
Featured Video
48:22
Lilly Diabetes
A Journey Through Clinical Efficacy and Safety Data Comparing Two T2…
Feat.
B. Hirsch
Related Content
AUTOPLAY
ON
47:11
Houston Methodist Hospital
The Protein Myth: Our Obsession With Protein and How It Is Killing US
Feat.
G. Davis
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
Primer on Diabetes Management
Feat.
S. Inzucchi
11:37
ACC 2022 Conference Coverage
ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…
Feat.
P. Heidenreich
49:21
Physicians Committee for Responsible Medicine
Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…
Feat.
T. J. Key
11:25
ACC 2023 Conference Coverage
ACC 2023: SGLT2i Use - Dos and Don'ts
Feat.
A. Armbruster
23:35
Practical Ways to Achieve Targets in Diabetes Care
Is There a Future for HbA1c? (Moving Towards CGM: GMI and TIR)
Feat.
I. Hirsch
18:43
ASPC 2019 Congress on CVD Prevention
Diabetes Treatment Guidelines Finally Have Entered the 21st Century …
Feat.
R. DeFronzo
15:06
Robert Busch
GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!
37:21
University of Colorado Department of Medicine
Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…
Feat.
R. Johnson
26:01
Cardiology Fiesta 2017
Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…
Feat.
R. DeFronzo
12:26
Juan Frias
SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide
15:33
Ken Fujioka
Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…
08:46
Robert Busch
FLOW Trial Results: GLPs, the Kidneys, and Even More to Come!!
27:24
Cardiometabolic Health Congress (CMHC)
SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes
Feat.
L. Sloan
26:49
Diana Isaacs
Tirzepatide Updates
13:01
CCM® Therapy
EHRA 2024: Ongoing Clinical Investigations with Cardiac Contractilit…
Feat.
N. Varma
14:58
CCM® Therapy
EHRA 2024: Real-World Experience with Cardiac Contractility Modulati…
Feat.
J. Kuschyk
19:53
CCM® Therapy
EHRA 2024: Cardiac Contractility Modulation: Innovative Therapy for …
Feat.
V. Reddy,
N. Varma,
K. Kuck,
J. Kuschyk,
N. Aspromonte
26:32
Practical Ways to Achieve Targets in Diabetes Care
Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity
Feat.
S. Nissen
33:23
Keck School of Medicine of USC
Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…
Feat.
M. Goran